Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03716193 · ClinicalTrials.gov registry record · NA

Measurement of the Partial Pressure of Oxygen in Cutaneous Tumors Using Electron Paramagnetic Resonance (EPR) Oximetry

A NA study, sponsored by West Virginia University.

Terminated
Registry status
NA
Development phase
3
Enrollment target

NCT03716193 is a NA study that was terminated before completion, run by West Virginia University. The registered enrollment target is 3 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03716193, a NA study, was terminated before completion, sponsored by West Virginia University.

TERMINATED
Registry status
NA
Development phase
3 participants
Enrollment target

Study Summary

This protocol will take measurements of a variety of tumors involving the skin in order to assess changes in tumor oxygen from hyperoxygenation therapy and standard cancer-directed treatments, to demonstrate the clinical feasibility of using in vivo Electron Paramagnetic Resonance (EPR) Oximetry to obtain clinically useful measurements of tumor oxygen levels from cancer patients.

Interventions

  • OTHER Oxygen

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2019-10-17
Est. Completion 2022-03-31
Phase NA

Sponsor

West Virginia University

122 total trials

What the Registry Record Tells You About NCT03716193

The ClinicalTrials.gov registry entry for NCT03716193 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is West Virginia University, which has 122 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Oxygen is the first listed.

NCT03716193 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03716193 about?

NCT03716193 is a clinical study titled "Measurement of the Partial Pressure of Oxygen in Cutaneous Tumors Using Electron Paramagnetic Resonance (EPR) Oximetry". This protocol will take measurements of a variety of tumors involving the skin in order to assess changes in tumor oxygen from hyperoxygenation therapy and standard cancer-directed treatments, to demonstrate the clinical feasibility of using in vivo Electron Paramagnetic Resonance (EPR) Oximetry to ...

What is the current status of trial NCT03716193?

This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2019-10-17. Estimated completion is 2022-03-31.

What interventions are being tested in trial NCT03716193?

The interventions under investigation include: Oxygen (OTHER).

Who is sponsoring clinical trial NCT03716193?

This trial is sponsored by West Virginia University, which has 122 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.